Stay updated on Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.

Latest updates to the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new page revision label v3.7.0 has been added to the study history, replacing the previous revision v3.6.6.SummaryDifference0.1%

- Check22 days agoChange DetectedOn 2026-09-10 the record shows that results have been posted and new sections for Adverse Events, Baseline Characteristics, Contacts/Locations, and Study Status were added (with 2026-08-18 represented as version 53). The prior 2026-05-05 'Results Submitted' entry was removed.SummaryDifference0.4%

- Check37 days agoChange DetectedRevision: v3.6.6 is now shown on the page, replacing Revision: v3.6.5. This indicates a minor platform update that does not affect the study content or user interactions.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s revision tag updated from Revision: v3.6.4 to Revision: v3.6.5, signaling a minor system update. This change does not affect the study data or history content displayed on the page.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision 3.6.4 was issued, adding new sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Document Section, References, and Study Status, and the record was returned on 2026-07-23. The update also shows that the Quality Control Review Has Not Concluded and that the previous revision 3.6.3 was removed.SummaryDifference0.8%

- Check94 days agoChange DetectedA new 'Results Submitted' addition is shown and the latest revision is 'Revision: v3.6.3'. The entries 'No Results Posted' and 'Revision: v3.6.2' have been removed.SummaryDifference0.1%

Stay in the know with updates to Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.